跳到正文

科迪华

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 6 条

  1. 2023

    杜邦及相关公司和解俄亥俄州 PFAS 诉讼

    和解

    俄亥俄州与杜邦及其分拆公司科慕、科迪华就环境污染诉讼达成和解,金额为 1.1 亿美元。和解款将用于 PFAS 污染治理等工作,但俄亥俄州仍可就相关污染采取饮用水执法行动。

    当事方说明的目的. 和解款将用于俄亥俄州 PFAS 治理,包括污染治理、消防泡沫清理和自然资源相关减缓工作。

    来源摘录

    • On December 1, 2023, it was announced that the state of Ohio had settled an environmental pollution lawsuit (State of Ohio v. E.I. du Pont de Nemours and Co., et al.) against DuPont (and spinoff companies Chemours and Corteva) for $110 million.
    • The case pertained to PFAS releases from DuPont’s Washington Works, West Virginia facility, which borders Ohio.
    • Thursday, November 30, 2023
  2. 2023

    Corteva 就涉嫌种子性状盗用起诉 Inari

    提起诉讼

    Corteva 在联邦法院起诉 Inari,指称 Inari 修改了 Corteva 种子中的生物技术性状,并试图为其申请美国专利。这些内容是诉讼中的指控,并非法院认定。

    来源摘录

    • The lawsuit alleges that Inari deliberately used a third-party agent to obtain protected Corteva seeds, illegally exported the seeds out of the United States, made slight genetic modifications of the biotech traits and is seeking U.S. patents for those modified traits,
    • Corteva is suing seed startup Inari for intellectual property theft, alleging in a lawsuit filed in federal court Wednesday that Inari tweaked biotech traits in Corteva’s seeds and is now trying to obtain U.S. patents for them.
    • Corteva filed suit Wednesday in U.S. District Court in Delaware against Inari USA and a sister operation, Inari Belgium. The suit alleges patent infringement, breach of material transfer agreements and infringement of U.S. Plant Protection Certificates.
  3. 2023

    CFPUA就重组起诉DuPont、Chemours及相关公司

    提起诉讼

    Cape Fear公共事业管理局提起诉讼,要求阻止Chemours、DuPont及相关公司进行其称可能规避Fayetteville Works工厂PFAS排放损害责任的重组,并要求赔偿。相关说法属于诉讼指控。

    来源摘录

    • CFPUA’s lawsuit names EIDP, Corteva, DuPont De Nemours and Chemours.
    • The Chemours Fayetteville Works plant has been discharging PFAS into the Cape Fear for the past several years.
  4. 2022

    农药折扣计划反垄断指控

    联邦贸易委员会指控Corteva和先正达运营的折扣计划可能阻止或限制美国部分农药市场的仿制药竞争。在2024年联邦法官驳回驳回动议后,诉讼仍然活跃。

  5. 2020

    毒死蜱健康与监管争议

    Corteva在需求下降和与儿童可能神经影响相关的限制下停止生产毒死蜱。

  6. 2019

    比格犬杀菌剂测试争议

    Corteva在委托对36只比格犬进行杀菌剂监管测试后受到公众批评。在美国人道协会的反对下,该公司同意停止测试并释放这些动物供领养。